Tamiflu Removed from Iran’s COVID-19 Treatment Protocol

Tamiflu Not Effective in Treating COVID-19: Iran

Deputy Health Minister Alireza Raisi says a new treatment protocol for COVID-19 has been communicated for implementation across the country, the main alteration being the removal of Tamiflu from COVID-19 treatment protocol.

Raisi’s comments came a few days after health ministry spokesman announced studies show Tamiflu does not prevent or treat the coronavirus disease.

“The matter was raised in the scientific committees and also discussed in the National Headquarters to Fight against Coronavirus,” he tweeted on March 16.

Tamiflu is a prescription medicine used to treat the flu (influenza) in people two weeks of age and older who have had flu symptoms for no more than 2 days. Tamiflu can also reduce the chance of getting the flu in people 1 year and older. Tamiflu does not prevent bacterial infections that may happen with the flu.

Tamiflu belongs to a class of drugs called antivirals. It’s an influenza neuraminidase inhibitor, which prevents the flu virus from multiplying (making more virus) inside your body.

Tamiflu comes in two forms, both of which are taken by mouth. These forms include capsules and a liquid suspension.

Tamiflu is a drug to treat the flu, and it will not protect people from getting the new coronavirus. Researchers internationally have been working to develop antivirals, but at the present time, there is no specific treatment or vaccine.

The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.


Please enter your comment!
Please enter your name here